Loading Events
Find Events

Event Views Navigation

Upcoming Events

Events List Navigation

December 2018

Exploring Human Host-Microbiome Interaction in Health and Disease

December 5 - December 7

The 7th Exploring Human Host-Microbiome Interactions in Health and Disease meeting will once again bring together leading scientists and clinicians from the fields of microbiology, gastroenterology, neuroscience, cancer and public health to discuss the latest developments in this fast-moving area.

Recent studies have revealed the complexity of the gut microbial ecology and its network connectivity to the metabolic regulation of important pathways in the host. Studies on microbiota from various body sites are helping us to understand how microorganisms affect the host. Alterations in microbiome composition have been associated with many non-infectious diseases including inflammatory bowel conditions, autoimmune diseases, cancers and diabetes, although in many cases causality has yet to be established.

This meeting will update current knowledge of how various microbiomes (oral, gut, lung, non-bacterial etc.) communicate with the host and the factors that influence these interactions. The programme will discuss the new developments enabled by metagenomics, metabolomics and other technologies. Attendees will have the opportunity to participate in discussions on how to apply recent discoveries to disease processes, health restoration and maintenance.

This year’s meeting will also include sessions on the gut-brain access and the influence of the microbiome on cancer. As in previous years, the warm welcome given to students and the open friendly atmosphere provide attendees with an enjoyable conference.

Find out more »

47th Annual AANS/CNS Section on Pediatric Neurological Surgery Meeting

December 6 - December 9

This year’s speakers at the Annual AANS/CNS Section on Pediatric Neurosurgery meeting include well-known experts who will present their unique, relevant and fascinating knowledge of their respective industries

Location: Nashville, TN, USA

Find out more »
January 2019

ANGEL (Advanced Neurotherapeutic Grant of Excellence) Award

January 1, 2019

Sponsor: International Rett Syndrome Foundation (IRSF)
Due Date: Applications accepted on a rolling basis
Award: Up to $600,000 over two years

Find out more »

The Biomarkers Consortium

January 1, 2019

Sponsor: Foundation for the National Institutes of Health
Due Date: Rolling basis
Award: If a project idea is approved for further development and implementation, the Foundation for the National Institutes of Health will seek funding to support the resulting project and manage its execution.

Find out more »

Cycle 2: NIH Small Business Grant

January 5, 2019

DUE DATE: January 5, 2019

Small Business Innovation Research (SBIR): These programs congressionally require eligible governmental agencies to set aside a percentage of their extramural budget so that domestic small businesses can engage in R&D that has a strong potential for technology commercialization. Total costs for Phase I and Phase II usually do not exceed $1,150,000; no funding is provided for Phase III.

Small Business Technology Transfer (STTR): These programs congressionally require eligible governmental agencies to set aside a percentage of their extramural budget so that domestic small businesses can engage in R&D that has a strong potential for technology commercialization. Total costs for Phase I and Phase II usually do not exceed $1,150,000; no funding is provided for Phase III.

Find out more »

Cycle 2: NIH R41, R42, R43, R44, U43, U44

January 5, 2019

DUE DATE: JANUARY 5, 2019

BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR)(R43/R44 Clinical Trial Not Allowed): The purpose of this funding opportunity announcement (FOA) is to support the development of novel tools and technologies through the Small Business Innovation Research (SBIR) program to advance the field of neuroscience research. Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase I and $1,500,000 for Phase II).

BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR)(R41/R42 Clinical Trial Not Allowed): The purpose of this funding opportunity announcement (FOA) is to support the development of novel tools and technologies through the Small Business Technology Transfer (STTR) program to advance the field of neuroscience research. Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase I and $1,500,000 for Phase II).

Find out more »
+ Export Events